Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line.
暂无分享,去创建一个
T. Ashizawa | A. Iizuka | Ryota Kondou | H. Miyata | T. Sugino | K. Yamaguchi | Y. Akiyama | Y. Nakasu | A. Asai | K. Urakami | K. Mitsuya | C. Nonomura | N. Hayashi